Document:

EX-4.2

 Exhibit 4.2 

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR
THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION. 
 WARRANT TO PURCHASE
STOCK 
  

			
	Company:	  	AppDynamics, Inc., a Delaware corporation
	Number of Shares:	  	As set forth below
	Type/Series of Stock:	  	Common Stock, $0.001 par value per share
	Warrant Price:	  	$1.60 per Share, subject to adjustment
	Issue Date:	  	February 12, 2014
	Expiration Date:	  	February 11, 2024 See also Section 5.1(b).
	Credit Facility:	  	This Warrant to Purchase Stock (“Warrant”) is issued in connection with that certain Subordinated Loan and Security Agreement of even date herewith between [Holder Name] and the Company (as amended and/or
modified and in effect from time to time, the “Loan Agreement”).

 THIS WARRANT CERTIFIES THAT, for good and valuable consideration, [Holder Name] (together with any successor
or permitted assignee or transferee of this Warrant or of any shares issued upon exercise hereof, “Holder”) is entitled to purchase up to the number of fully paid and non-assessable shares of the above-stated Type/Series of
Stock (the “Class”) of the above-named company (the “Company”) as determined pursuant to Paragraph A below, at the above-stated Warrant Price, all as set forth above and as adjusted pursuant to
Section 2 of this Warrant, subject to the provisions and upon the terms and conditions set forth in this Warrant. 
 A. Number of
Shares. This Warrant shall be exercisable for the Initial Shares, plus the Additional Shares, if any (collectively, and as may be adjusted from time to time pursuant to the provisions of this Warrant, the “Shares”). 

(1) Initial Shares. As used herein, “Initial Shares” means 25,205 shares of the Class, subject to adjustment
from time to time pursuant to the provisions of this Warrant. 
 (2) Additional Shares. On and after the date on which the aggregate
of Term Loan Advances (as defined in the Loan Agreement) made to the Company exceeds $5,000,000, and regardless of whether any such Term Loan Advance is then still outstanding, on each Term Loan Advance to the Company in excess of such $5,000,000
(an “Additional Term Loan Advance”), this Warrant automatically shall become exercisable for such number of additional shares of the Class as shall equal (a) the Additional Shares Pool, multiplied by (b) a fraction,
the numerator of which shall equal the amount of such Additional Term Loan Advance and the denominator of which shall equal $15,000,000, subject to adjustment thereafter from time to time in accordance with the

 
provisions of this Warrant. All shares, if any, for which this Warrant becomes exercisable pursuant to this Paragraph A(2) are referred to herein cumulatively as the “Additional
Shares.” 
 (3) Additional Shares Pool. As used herein, “Additional Shares Pool” means 75,613
shares of the Class, as such number may be adjusted from time to time in accordance with the provisions of this Warrant. 

SECTION 1. EXERCISE. 

1.1 Method of Exercise. Holder may at any time and from time to time exercise this Warrant, in whole or in part, by delivering to the
Company the original of this Warrant together with a duly executed Notice of Exercise in substantially the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to a cashless exercise set forth in
Section 1.2, a check, wire transfer of same-day funds (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate Warrant Price for the Shares being purchased. 

1.2 Cashless Exercise. On any exercise of this Warrant, in lieu of payment of the aggregate Warrant Price in the manner as specified in
Section 1.1 above, but otherwise in accordance with the requirements of Section 1.1, Holder may elect to receive Shares equal to the value of this Warrant, or portion hereof as to which this Warrant is being exercised. Thereupon, the
Company shall issue to the Holder such number of fully paid and non-assessable Shares as are computed using the following formula: 
  

							
	X	 	 	=	  	 	Y(A-B)/A

 where: 
  

							
	X	 	 	=	  	 	the number of Shares to be issued to the Holder;
			
	Y	 	 	=	  	 	the number of Shares with respect to which this Warrant is being exercised (inclusive of the Shares surrendered to the Company in payment of the aggregate Warrant Price);
			
	A	 	 	=	  	 	the Fair Market Value (as determined pursuant to Section 1.3 below) of one Share; and
			
	B	 	 	=	  	 	the Warrant Price.

 1.3 Fair Market Value. If shares of the Class are then traded or quoted on a nationally recognized
securities exchange, inter-dealer quotation system or over-the-counter market (a “Trading Market”), the fair market value of a Share shall be the closing price or last sale price of a share of the Class reported for the
Business Day immediately before the date on which Holder delivers this Warrant together with its Notice of Exercise to the Company. If shares of the Class are not then traded in a Trading Market, the Board of Directors of the Company shall determine
the fair market value of a Share in its reasonable good faith judgment. 

  
 -2- 

 1.4 Delivery of Certificate and New Warrant. Within a reasonable time after Holder
exercises this Warrant in the manner set forth in Section 1.1 or 1.2 above, the Company shall deliver to Holder a certificate representing the Shares issued to Holder upon such exercise and, if this Warrant has not been fully exercised and has
not expired, a new warrant of like tenor representing the Shares not so acquired. 
 1.5 Replacement of Warrant. On receipt of
evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form, substance and amount
to the Company or, in the case of mutilation, on surrender of this Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of this Warrant, a new warrant of like tenor and amount.

 1.6 Treatment of Warrant Upon Acquisition of Company. 

(a) Acquisition. For the purpose of this Warrant, “Acquisition” means any transaction or series of related
transactions involving: (i) the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company (ii) any merger or consolidation of the Company into or with another person or entity (other than
a merger or consolidation effected exclusively to change the Company’s domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity as such immediately prior to such merger, consolidation or
reorganization, own less than a majority of the Company’s (or the surviving or successor entity’s) outstanding voting power immediately after such merger, consolidation or reorganization (or, if such Company stockholders beneficially own a
majority of the outstanding voting power of the surviving or successor entity as of immediately after such merger, consolidation or reorganization, such surviving or successor entity is not the Company); or (iii) any sale or other transfer by
the stockholders of the Company of shares representing at least a majority of the Company’s then-total outstanding combined voting power. 

(b) Treatment of Warrant at Acquisition. In the event of an Acquisition in which the consideration to be received by the
Company’s stockholders consists solely of cash, solely of Marketable Securities or a combination of cash and Marketable Securities (a “Cash/Public Acquisition”), and the fair market value of one Share as determined in
accordance with Section 1.3 above would be greater than the Warrant Price in effect on such date immediately prior to such Cash/Public Acquisition, and Holder has not exercised this Warrant pursuant to Section 1.1 above as to all Shares,
then this Warrant shall automatically be deemed to be Cashless Exercised pursuant to Section 1.2 above as to all Shares effective immediately prior to and contingent upon the consummation of a Cash/Public Acquisition. In connection with such
Cashless Exercise, Holder shall be deemed to have restated each of the representations and warranties in Section 4 of the Warrant as the date thereof and the Company shall promptly notify the Holder of the number of Shares (or such other
securities) issued upon exercise. In the event of a Cash/Public Acquisition where the fair market value of one Share as determined in accordance with Section 1.3 above would be less than the Warrant Price in effect immediately prior to such
Cash/Public Acquisition, then this Warrant will expire immediately prior to the consummation of such Cash/Public Acquisition. 

  
 -3- 

 (c) In connection with any Acquisition other than a Cash/Public Acquisition, the Company agrees
to use its commercially reasonable efforts to procure the assumption of this Warrant and the Company’s obligations hereunder at the closing thereof by the acquiring, surviving or successor entity, in which case this Warrant shall thereafter be
exercisable for the same securities and/or other property as would have been paid for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on and as of the closing of such Acquisition,
subject to further adjustment from time to time in accordance with the provisions of this Warrant. If this Warrant shall not be assumed at the closing of such Acquisition by such acquiring, surviving or successor entity, it shall terminate upon such
closing to the extent not previously exercised. 
 (d) As used in this Warrant, “Marketable Securities” means securities
meeting all of the following requirements: (i) the issuer thereof is then subject to the reporting requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and is then current in its filing of all required reports and other information under the Act and the Exchange Act; (ii) the class and series of shares or other security of the issuer that would be received by Holder in connection with the
Acquisition were Holder to exercise this Warrant on or prior to the closing thereof is then traded in Trading Market, and (iii) following the closing of such Acquisition, Holder would not be restricted from publicly re-selling all of the
issuer’s shares and/or other securities that would be received by Holder in such Acquisition were Holder to exercise this Warrant in full on or prior to the closing of such Acquisition, except to the extent that any such restriction
(x) arises solely under federal or state securities laws, rules or regulations, and (y) does not extend beyond six (6) months from the closing of such Acquisition. 

SECTION 2. ADJUSTMENTS TO THE SHARES AND WARRANT PRICE. 

2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a dividend or distribution on all of the outstanding shares of the
Class payable in additional shares of the Class or other securities or property (other than cash), then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without additional cost to Holder, the total number and kind of
securities and property which Holder would have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company subdivides the outstanding shares of the Class by reclassification or otherwise into
a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased. If the outstanding shares of the Class are combined or consolidated, by
reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately decreased. 

2.2 Reclassification, Exchange, Combinations or Substitution. Upon any event whereby all of the outstanding shares of the Class are
reclassified, exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from and after the consummation of such event, this Warrant will be exercisable for the number, class and
series of Company securities that Holder would have received had the Shares been outstanding on and as of the consummation of such event, and subject to further adjustment thereafter from time to time in accordance with the provisions of this
Warrant. The provisions of this Section 2.2 shall 

  
 -4- 

 
similarly apply to successive reclassifications, exchanges, combinations substitutions, replacements or other similar events. 

2.3 No Fractional Share. No fractional Share shall be issuable upon exercise of this Warrant and the number of Shares to be issued
shall be rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise of the Warrant, the Company shall eliminate such fractional Share interest by paying Holder in cash the amount computed by multiplying the
fractional interest by (i) the fair market value (as determined in accordance with Section 1.3 above) of a full Share, less (ii) the then-effective Warrant Price. 

2.4 Notice/Certificate as to Adjustments. Upon each adjustment of the Warrant Price, Class and/or number of Shares, the Company, at the
Company’s expense, shall notify Holder in writing within a reasonable time setting forth the adjustments to the Warrant Price, Class and/or number of Shares and facts upon which such adjustment is based. The Company shall, upon written request
from Holder, furnish Holder with a certificate of its Chief Financial Officer, including computations of such adjustment and the Warrant Price, Class and number of Shares in effect upon the date of such adjustment. 

SECTION 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY. 

3.1 Representations and Warranties. The Company represents and warrants to, and agrees with, the Holder as follows: 

(a) The aggregate of the Initial Shares plus the Additional Shares Pool first set forth above represents not less than 0.095% of the
Company’s total issued and outstanding shares of common stock, calculated on and as of the Issue Date hereof on a fully-diluted basis, assuming (i) the conversion into common stock of all outstanding securities and instruments (including,
without limitation, securities deemed to be outstanding pursuant to clause (ii) of this Section 3.1(a)) convertible by their terms into shares of common stock (regardless of whether such securities or instruments are by their terms now so
convertible), and (ii) the exercise in full of all outstanding options, warrants (including, without limitation, this Warrant) and other rights to purchase or acquire shares of common stock or securities exercisable for or convertible into
shares of common stock (regardless of whether such options, warrants or other rights to purchase or acquire are by their terms now exercisable). 

(b) The initial Warrant Price referenced on the first page of this Warrant is not greater than the fair market value of a share of the Class
as determined by the most recent to have occurred of (i) a valuation of the Company’s stock for purposes of its compliance with Section 409A of the Internal Revenue Code of 1986, as amended, and (ii) a determination by the
Company’s Board of Directors in connection with the Company’s grant of employee incentive stock options. 
 (c) All Shares which
may be issued upon the exercise of this Warrant shall, upon issuance, be duly authorized, validly issued, fully paid and non-assessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under
applicable federal and state securities laws. The Company covenants that it shall at all times cause to 

  
 -5- 

 
be reserved and kept available out of its authorized and unissued capital stock such number of shares of the Class and other securities as will be sufficient to permit the exercise in full of
this Warrant. 
 (d) The Company’s capitalization table attached hereto as Schedule 1 is true and complete, in all material respects,
as of the Issue Date. 
 3.2 Notice of Certain Events. If the Company proposes at any time to: 

(a) declare any dividend or distribution upon all of the outstanding shares of the Class, whether in cash, property, stock, or other
securities and whether or not a regular cash dividend; 
 (b) offer for subscription or sale pro rata to the holders of the outstanding
shares of the Class any additional shares of any class or series of the Company’s stock (other than pursuant to contractual pre-emptive or anti-dilution rights); 

(c) effect any reclassification, exchange, combination, substitution, reorganization or recapitalization of all of the outstanding shares of
the Class; 
 (d) effect an Acquisition or a liquidation, dissolution or winding up of the Company; or 

(e) effect its initial, underwritten offering and sale of its securities to the public pursuant to an effective registration statement under
the Act (the “IPO”); 
 then, in connection with each such event, the Company shall give Holder: 

 

	 	(1)	in the case of the matters referred to in (a) and (b) above, at least seven (7) Business Days prior written notice of the earlier to occur of the effective date thereof or the date on which a record will
be taken for such dividend, distribution, or subscription rights (and specifying the date on which the holders of outstanding shares of the Class will be entitled thereto) or for determining rights to vote, if any; 

 

	 	(2)	in the case of the matters referred to in (c) and (d) above at least seven (7) Business Days prior written notice of the date when the same will take place (and specifying the date on which the holders of
outstanding shares of the Class will be entitled to exchange their shares for the securities or other property deliverable upon the occurrence of such event and such reasonable information as Holder may reasonably require regarding the treatment of
this Warrant in connection with such event giving rise to the notice); and 

  

	 	(3)	with respect to the IPO, at least seven (7) Business Days prior written notice of the date on which the Company proposes to file its registration statement in connection therewith. 

The Company will also provide information requested by Holder that is reasonably necessary to enable Holder to comply with Holder’s accounting or
reporting requirements. 

  
 -6- 

 SECTION 4. REPRESENTATIONS, WARRANTIES OF THE HOLDER. 

The Holder represents and warrants to the Company as follows: 

4.1 Purchase for Own Account. This Warrant and the Shares to be acquired upon exercise of this Warrant by Holder are being acquired
for investment for Holder’s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Act. Holder also represents that it has not been formed for the specific purpose of acquiring
this Warrant or the Shares. 
 4.2 Disclosure of Information. Holder is aware of the Company’s business affairs and financial
condition and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and its underlying securities. Holder further has
had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information (to the extent the Company possessed such
information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access. 

4.3 Investment Experience. Holder understands that the purchase of this Warrant and its underlying securities involves substantial
risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk of such Holder’s investment in this Warrant and its underlying securities and has such
knowledge and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities and/or has a preexisting personal or business relationship with the
Company and certain of its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial circumstances of such persons. 

4.4 Accredited Investor Status. Holder is an “accredited investor” within the meaning of Regulation D promulgated under
the Act. 
 4.5 The Act. Holder understands that this Warrant and the Shares issuable upon exercise hereof have not been registered
under the Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent as expressed herein. Holder understands that this Warrant and the Shares
issued upon any exercise hereof must be held indefinitely unless subsequently registered under the Act and qualified under applicable state securities laws, or unless exemption from such registration and qualification are otherwise available. Holder
is aware of the provisions of Rule 144 promulgated under the Act. 
 4.6 No Voting Rights. Holder, as a Holder of this Warrant, will
not have any voting rights until the exercise of this Warrant. 
 4.7 Market Stand-off Agreement. Holder shall not sell or otherwise
transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar 

  
 -7- 

 
transaction with the same economic effect as a sale, of any Common Stock (or other securities) of the Company held by Holder (other than those included in the registration) during the one hundred
and eighty (180) day period following the effective date of the registration statement for the IPO (or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (i) the publication or
other distribution of research reports and (ii) analyst recommendations and opinions, including, but not limited to, the restrictions contained in FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto).
The obligations described in this Section 4.7 shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a
transaction on Form S-4 or similar forms that may be promulgated in the future. The Company may impose stop-transfer instructions with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of
such one hundred and eighty (180) day (or other) period. Holder agrees to execute a market standoff agreement with said underwriters in customary form consistent with the provisions of this Section 4.7. The obligations described in this
Section 4.7 shall apply only if all officers and directors of the Company and all one percent (1%) securityholders shall have entered into and are bound by similar agreements, and shall not apply to a registration relating solely to
employee benefit plans, or to a registration relating solely to a transaction pursuant to Rule 145 under the Act. 
 SECTION 5.
MISCELLANEOUS. 
 5.1 Term; Automatic Cashless Exercise Upon Expiration. 

(a) Term. Subject to the provisions of Section 1.6 above, this Warrant is exercisable in whole or in part at any time and from
time to time on or before 6:00 PM, Pacific time, on the Expiration Date and shall be void thereafter. 
 (b) Automatic Cashless Exercise
upon Expiration. In the event that, upon the Expiration Date, the fair market value of one Share as determined in accordance with Section 1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall
automatically be deemed on and as of such date to be exercised pursuant to Section 1.2 above as to all Shares for which it shall not previously have been exercised, and the Company shall, within a reasonable time, deliver a certificate
representing the Shares issued upon such exercise to Holder. 
 5.2 Legends. Each certificate evidencing Shares shall be imprinted
with a legend in substantially the following form: 
 THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO [HOLDER NAME] DATED FEBRUARY 12, 2014, MAY
NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO 

  
 -8- 

 
THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION. 

5.3 Compliance with Securities Laws on Transfer. This Warrant and the Shares issued upon exercise of this Warrant may not be
transferred or assigned in whole or in part except in compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation letters and legal
opinions reasonably satisfactory to the Company, as reasonably requested by the Company). The Company shall not require Holder to provide an opinion of counsel if the transfer is to an affiliate of Holder, provided that any such transferee is an
“accredited investor” as defined in Regulation D promulgated under the Act. Additionally, the Company shall also not require an opinion of counsel if there is no material question as to the availability of Rule 144 promulgated under
the Act. 
 5.4 Transfer Procedure. Subject to the provisions of Section 5.3 and upon providing the Company with written
notice, [Holder Name] may transfer all or part of this Warrant or the Shares issued upon exercise of this Warrant to any transferee, provided, however, in connection with any such transfer, [Holder Name] will give the Company notice of the portion
of the Warrant and/or Shares being transferred with the name, address and taxpayer identification number of the transferee and Holder will surrender this Warrant to the Company for reissuance to the transferee(s) (and Holder if applicable); and
provided further, that any transferee shall agree in writing with the Company to be bound by all of the terms and conditions of this Warrant. Notwithstanding any contrary provision herein, at all times prior to the IPO, Holder may not, without the
Company’s prior written consent, transfer this Warrant or any portion hereof, or any Shares issued upon any exercise hereof, to any person or entity who directly competes with the Company, except in connection with an Acquisition of the Company
by such a direct competitor. 
 5.5 Notices. All notices and other communications hereunder from the Company to the Holder, or vice
versa, shall be deemed delivered and effective (i) when given personally, (ii) on the third (3rd) Business Day after being mailed by first-class registered or certified mail,
postage prepaid, (iii) upon actual receipt if given by facsimile or electronic mail and such receipt is confirmed in writing by the recipient, or (iv) on the first Business Day following delivery to a reliable overnight courier service,
courier fee prepaid, in any case at such address as may have been furnished to the Company or Holder, as the case may be, in writing by the Company or such Holder from time to time in accordance with the provisions of this Section 5.5. All
notices to Holder shall be addressed as follows until the Company receives notice of a change of address in connection with a transfer or otherwise: 

[Holder Name and address] 

Notice to the Company shall be addressed as follows until Holder receives notice of a change in address: 

  
 -9- 

 AppDynamics, Inc. 

Attn: Chief Financial Officer 

303 Second Street 

North Tower, 8th Floor 

San Francisco, CA 94107 

With a copy (which shall not constitute notice) to: 

AppDynamics, Inc. 

303 2nd Street 

North Tower, 8th Floor 

San Francisco, CA 94107 

Attn: Director of Legal 

5.6 Waiver. This Warrant and any term hereof may be changed, waived, discharged or terminated (either generally or in a particular
instance and either retroactively or prospectively) only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 

5.7 Attorneys’ Fees. In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the
party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees. 

5.8 Counterparts; Facsimile/Electronic Signatures. This Warrant may be executed in counterparts, all of which together shall
constitute one and the same agreement. Any signature page delivered electronically or by facsimile shall be binding to the same extent as an original signature page with regards to any agreement subject to the terms hereof or any amendment thereto.

 5.9 Governing Law. This Warrant shall be governed by and construed in accordance with the laws of the State of California,
without giving effect to its principles regarding conflicts of law. 
 5.10 Headings. The headings in this Warrant are for purposes
of reference only and shall not limit or otherwise affect the meaning of any provision of this Warrant. 
 5.11 Business Days.
“Business Day” is any day that is not a Saturday, Sunday or a day on which [Holder Name] is closed. 
 [Remainder of
page left blank intentionally] 
 [Signature page follows] 

  
 -10- 

 IN WITNESS WHEREOF, the parties have caused this Warrant to Purchase Stock to be executed by
their duly authorized representatives effective as of the Issue Date written above. 
  

			
	“COMPANY”
	
	APPDYNAMICS, INC.
		
	By:	 	 
		
	Name:	 	 
		 	(Print)
	Title:	 	

  

			
	“HOLDER”
		
	By:	 	 
		
	Name:	 	 
		 	(Print)
	Title:	 	

  
 -11- 

 APPENDIX 1 

NOTICE OF EXERCISE 

1. The undersigned Holder hereby exercises its right to purchase
            shares of the Common Stock of             (the “Company”) in accordance with the attached
Warrant To Purchase Stock, and tenders payment of the aggregate Warrant Price for such shares as follows: 
  

	 	 ̈	check in the amount of $            payable to order of the Company enclosed herewith 

 

	 	 ̈	Wire transfer of immediately available funds to the Company’s account 

  

	 	 ̈	Cashless Exercise pursuant to Section 1.2 of the Warrant 

  

	 	 ̈	Other [Describe] 

 2. Please issue a certificate or certificates representing the Shares in the
name specified below: 
  

	
	 
	  

	Holder’s Name
	
	 
	
	 
	(Address)

 3. By its execution below and for the benefit of the Company, Holder hereby restates each of the
representations and warranties in Section 4 of the Warrant to Purchase Stock as of the date hereof. 
  

			
	HOLDER:
		
	 	 	 
		
	By:	 	 
		
	Name:	 	
		
	Title:	 	
		
	(Date):	 	

  
 Appendix 1EX-4.3

 Exhibit 4.3 

ALLOCATION AGREEMENT 

This Allocation Agreement (the “Agreement”) is made and entered into as of November 8, 2015, by and between AppDynamics,
Inc., a Delaware corporation (the “Company”) and General Atlantic (AD), L.P. (the “Investor”). All capitalized terms not otherwise defined shall have the respective meanings ascribed thereto in Section 4. 

WHEREAS, concurrently with the execution of this Agreement, (i) the Company and (ii) the Investor and certain other investors
(collectively, the “Series F Investors”) are executing an Amended and Restated Series F Preferred Stock Purchase Agreement (the “Series F Agreement”) which amends and restates that certain
Series F Preferred Stock Purchase Agreement dated October 16, 2015 (the “Prior Agreement”), pursuant to which the Investor is agreeing to purchase shares of the Company’s Series F Preferred Stock (the
“Series F Stock”); 
 WHEREAS, the purchase and sale of the Series F Stock pursuant to the Series F
Agreement and the Prior Agreement is referred to herein as the “Series F Financing”; and 
 WHEREAS, in consideration
of the Investor acting as a lead investor in the Series F Financing, the Company agrees to make certain arrangements to allow the Investor to participate in a future offering of the Company’s Common Stock in accordance with the terms and
conditions contained herein. 
 NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein, and for other good
and valuable consideration, the parties hereto agree as follows: 
 1. Allocation of Shares and Private Placement Right. 

1.1 Allocation. Subject to the requirements of the Securities Laws and Regulations and subject to the other provisions of this
Agreement, the Company agrees to use its reasonable best efforts (including reasonable cooperation with respect to obtaining applicable regulatory clearances) to provide Investor with the right, but not the obligation, to purchase from the Company,
in a separate and contemporaneous private placement transaction exempt from registration with the SEC (the “Private Placement”), up to the Investor Maximum Allocated Shares on the terms set forth in this Agreement. Any such purchase
of shares of Common Stock shall be at the same price per share at which such shares of Common Stock are being offered to the public pursuant to the Company’s registration statement with respect to a Qualified IPO. 

1.2 Notice of Qualified IPO. Within fifteen (15) business days after the Company first submits to, or files with, the SEC a
registration statement covering shares of its Common Stock for a Qualified IPO , the Company will notify the Investor in writing (the “Offering Notice”) of the Company’s intent to undertake the Qualified IPO, which shall
include, if known at the time of such Offering Notice, (i) the approximate date that the Company expects to print and distribute preliminary prospectuses relating to the Qualified IPO, (ii) the anticipated closing date of the Qualified IPO
and (iii) the actual number of shares of Common Stock to be allocated to the Investor. The Company and the Investor acknowledge that the schedule will be based upon the Company’s reasonable best estimate at the time of the Offering Notice
but that such schedule is subject to substantial revision based upon market conditions, disclosure issues that may arise during the preparation of the registration statement, interaction with the SEC regarding the registration statement and other
factors. 

 1.3 Preliminary Indication of Interest. No later than fifteen (15) business days after the
delivery of the Offering Notice (the “Response Period”), the Investor may provide the Company with a non-binding written statement setting forth the aggregate dollar amount that the Investor is interested in purchasing in the
Private Placement. The Company and the Investor acknowledge that this indication of interest is not intended to be an offer to purchase from the Investor but merely an indication of interest to assist the Company in structuring the Private Placement
and preparing appropriate disclosure in the registration statement. The failure by the Investor to notify the Company within the Response Period of its interest in purchasing shares in the Private Placement shall terminate the Investor’s right
to purchase shares pursuant to the Private Placement, unless the Qualified IPO is not completed within one hundred eighty (180) days of the Offering Notice; in which case the Company shall not complete a Qualified IPO without again complying
with the provisions of this Section 1. 
 1.4 Final Indication of Interest. No later than the time at which the managing
underwriters for the Qualified IPO obtain final indications of interest from potential purchasers in the Qualified IPO (the “Pricing Deadline”), the Investor must provide the Company with the Investor’s final indication of
interest setting forth the number of shares of Common Stock that the Investor is interested in purchasing in the Private Placement. The failure by the Investor to notify the Company by the Pricing Deadline of its interest in purchasing shares in the
Private Placement shall terminate the Investor’s right to purchase shares pursuant to the Private Placement, unless the Qualified IPO is not completed within one hundred eighty (180) days of the Offering Notice; in which case the Company
shall not complete a Qualified IPO without again complying with the provisions of this Section 1. 
 1.5 Compliance with Securities
Laws and Regulations. Notwithstanding the Company’s exercise of its reasonable best efforts in accordance with Section 1.1, in the event that any such Private Placement would, in the Company’s reasonable judgment, based on the
advice of counsel for the Company and following consultation with the Investor, be deemed invalid as a private placement under the Act for any reason (including but not limited to by reason of the doctrine of “integration” with the
Qualified IPO) or would otherwise conflict with any Securities Laws and Regulations or give rise to any other legal impediment or legal requirement that would prevent or materially delay the consummation of or unreasonably interfere with the
Qualified IPO, then the Private Placement shall not occur and the Company, on the one hand, and the Investor, on the other hand, shall have no liability or obligation to one another in connection therewith; provided, however, that in such event the
Company will discuss good faith alternatives with the Investor and use reasonable best efforts to provide the Investor with a substantially equivalent investment opportunity. 

1.6 Closing. The closing of the Investor’s purchase of shares in the Private Placement pursuant to this Agreement shall take place
substantially simultaneously with the closing of the Company’s sale of shares to the underwriters in the Qualified IPO. The Company and the Investor agree that the terms and conditions of the Investor’s purchase of shares in the Private
Placement pursuant to this Agreement will be memorialized in, and governed by, a mutually agreeable written stock purchase agreement between the Company and the Investor (the “Private Placement SPA”) with customary terms and
provisions for such a transaction. The Investor and the Company agree to sign such other mutually agreed upon reasonable and customary documents, and take such other reasonable and customary actions as the other party may reasonably request, in
connection with such closing. 
 1.7 Conditionality. The right of the Investor to purchase shares in the Private Placement under this
Section 1 shall be conditioned, in each case, upon the completion of the Qualified IPO. The Company may withdraw any registration statement for a Qualified IPO at any time without thereby incurring any liability to the Investor or any permitted
assignee of the Investor or other party that has been apportioned rights hereunder. 

  
 -2- 

 1.8 Registration Rights. Any shares purchased by the Investor in the Private Placement
shall be deemed to be “Registrable Securities” as such term is defined in Section 1.1 of the Investors’ Rights Agreement. 

2. Qualified IPO Only. For the avoidance of doubt, subject to the obligations of the Company set forth in the proviso to
Section 1.5, the right of the Investor to purchase shares in the Private Placement under this Agreement shall only be applicable to any Private Placement conducted in connection with a Qualified IPO and not to any other offering of securities
by the Company, either before or after the consummation of the Qualified IPO. In the event that the Company undertakes to offer securities pursuant to a firm commitment underwritten public offering under the Act that does not qualify as a Qualified
IPO, the Investor shall have no rights or obligations under this Agreement in respect of, or as a result of, such offering, including without limitation, the rights and obligations described in Section 1 above, but this Agreement and all rights
and obligations hereunder shall remain in full force and effect until terminated pursuant to Section 6.7 below. 
 3. Restricted
Securities. 
 3.1 Restricted Securities and Market Stand-Off Terms. The Investor hereby agrees that any shares of Common Stock
acquired by the Investor pursuant to this Agreement shall be deemed to be “Restricted Securities” as such term is defined in Section 1.1 of the Investors’ Rights Agreement and as such shall be subject to Sections 2.8, 2.10
and 2.12 of the Investors’ Rights Agreement. 
 3.2 Legend. In order to enforce the foregoing covenant, the Company shall have
the right to place the following restrictive legend on the certificates representing the shares subject to this section and to impose stop transfer instructions with respect to such shares until the end of such period: 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AFTER THE EFFECTIVE DATE OF THE ISSUER’S
REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE. SUCH
LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 
 3.3 Additional Agreement. The Investor acknowledges its obligation
pursuant to Section 2.10 of the Investors’ Rights Agreement to execute a market standoff agreement with the underwriters in an Initial Public Offering (as defined in the Investors’ Rights Agreement) in customary form and consistent
with the provisions of Section 2.10 of the Investors’ Rights Agreement, subject to the limitations set forth in the Investors’ Rights Agreement. 

4. Certain Defined Terms. In addition to the terms defined above, the following terms shall have the following meanings: 

“Act” means the Securities Act of 1933, as amended. 

“Affiliate” means, with respect to any specified person, any other person who or which, directly or indirectly, controls, is
controlled by, or is under common control with such specified person, including, without limitation, any direct or indirect subsidiary of such person that is at least 50% controlled by such person, general partner, officer, director or manager of
such person and any venture capital or other 

  
 -3- 

 
investment fund now or hereafter existing that is controlled by one or more general partners or managing members of, or is under common investment management with, such person. 

“Common Stock” means the Company’s common stock, par value $0.001 per share. 

“FINRA” means the Financial Industry Regulatory Authority, Inc. and any successor organizations or entities thereto. 

“Investor Maximum Allocated Shares” means the number of shares of Common Stock equal to the greater of
(i) $25 million divided by the Qualified IPO price per share, or (ii) 15% of the total number of shares to be sold in the Qualified IPO (excluding any shares sold or to be sold pursuant to any over-allotment or green shoe option),
which in no event shall exceed $50 million divided by the Qualified IPO price per share. 
 “Investors’ Rights
Agreement” shall mean that certain Sixth Amended and Restated Investors’ Rights Agreement dated as of the date hereof, among the Company, the Series F Investors and certain other parties thereto, as amended or restated from time
to time. 
 “1934 Act” means the Securities Exchange Act of 1934, as amended. 

“Qualified IPO” means the Company’s first firm commitment underwritten public offering of its Common Stock under the
Act, provided that such offering results in aggregate gross cash proceeds to the Company of not less than $100,000,000 in the aggregate. 

“register,” “registered,” and “registration” refer to a registration effected by preparing
and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or document. 

“SEC” means the Securities and Exchange Commission. 

“Securities Laws and Regulations” means (i) all applicable federal, state or other securities laws (including but not
limited to the Act, as amended from time to time, and the rules and regulation from time to time promulgated thereunder, the 1934 Act, as amended from time to time, and the rules and regulation from time to time promulgated thereunder or the rules
and regulations of any securities exchange) and (ii) all rules and regulations of FINRA or any other self-regulatory organization that are applicable to the Company, the Investor or any underwriter participating in the Qualified IPO, as
applicable. 
 5. Publication. Neither the Investor nor any of its representatives shall disclose any confidential information
provided to or learned by it in connection with its rights under this Agreement, including the existence of this Agreement, to any third party (other than an officer, director, employee, general or limited partner, attorney, advisor, accountant,
agent or representative of such Investor who has a reason to know such information for and who has an obligation of confidentiality with respect to such information) unless otherwise required by law (including, without limitation, any rule or
regulation promulgated by the SEC or any other competent regulatory authority) or with the Company’s prior written consent. 
 6.
Miscellaneous. 
 6.1 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement
shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party 

  
 -4- 

 
other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in
this Agreement. Notwithstanding the foregoing, the rights of the Investor are assignable by the Investor, in whole or in part, only to one or more Affiliates of the Investor, and in each case, (i) only to the extent that any such assignment is
in compliance with all applicable laws, rules and regulations, including the Securities Laws and Regulations, and (ii) only if (x) the Company is, within a reasonable time prior to such transfer, furnished with written notice of the name
and address of each such proposed assignee or assignees and (y) each such proposed assignee or assignees agrees in writing to be bound by and subject to the terms and conditions of this Agreement, including without limitation, Section 3
hereof. 
 6.2 Governing Law. This Agreement shall be governed by and construed under the laws of the State of California as applied
to agreements among California residents entered into and to be performed entirely within California. 
 6.3 Counterparts. This
Agreement may be executed and delivered by facsimile or electronic signature (including pdf) and in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one (1) and the same instrument.

 6.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be
considered in construing or interpreting this Agreement. 
 6.5 Notices. All notices and other communications given or made pursuant
hereto shall be in writing and shall be deemed effectively given upon the earlier to occur of actual receipt or: (a) upon personal delivery to the party to be notified, (b) when sent by electronic mail if also confirmed by facsimile sent
during normal business hours of the recipient, effective as of the delivery of the facsimile; if not sent via facsimile during normal business hours, then on the next business day, (c) five (5) days after having been sent by registered or
certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be
sent to the respective parties at the addresses set forth on the signature pages attached hereto (or at such other addresses as shall be specified by notice given in accordance with this Section 6.5). 

6.6 Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party
shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

6.7 Term and Termination. This Agreement shall be effective as of the Third Closing (as defined in the Series F Agreement). This
Agreement, and all rights and obligations hereunder, shall terminate automatically and without further notice: (i) upon the consummation of a Qualified IPO and, without limiting the Investor’s rights under Section 1.5, the Private
Placement if the Investor has exercised its rights under Sections 1.3 and 1.4; (ii) upon the consummation of an initial public offering: (x) that is not a Qualified IPO, (y) where the Investor and its Affiliates convert all
shares of Series F Stock then held by them into Common Stock prior to such offering and (z) where the Investor is granted the right to participate in such offering or a concurrent private placement on the same terms and conditions as set
forth in this Agreement; (iii) in the event that the Investor and its Affiliates and their respective successors and permitted assigns collectively cease for any reason to continue to hold at least 3,500,000 shares of Series F Stock
(as adjusted for any stock dividends, combinations or splits with respect to such shares) that the Investor and its Affiliates originally purchased in the Series F Financing; or (iv) upon the consummation of any “Liquidation
Event” (as such is defined in the Company’s Amended and Restated Certificate of Incorporation, as the same may be amended, supplemented or otherwise modified from time to time). Notwithstanding the foregoing, (i) Section 1.8
shall 

  
 -5- 

 
survive the termination of this Agreement and (ii) the Company’s obligations set forth in the proviso to Section 1.5 shall survive the termination of this Agreement to the extent
that the Investor has indicated its interest in purchasing in the Private Placement in accordance with this Agreement and such Private Placement has not been consummated in connection with the Qualified IPO due to the circumstances set forth in
Section 1.5. Notwithstanding anything to the contrary herein, if the Series F Agreement terminates prior to the Third Closing, this Agreement shall be void ab initio. 

6.8 Entire Agreement; Amendments and Waivers. This Agreement and the other documents executed in connection with the Series F
Financing constitute the full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof and supersede any and all prior understandings and agreements, written or oral, between or among the parties hereto
with respect to the specific subject matter hereof. Any term of this Agreement may be amended only with the written consent of the Company and the Investor. The observance of any term of this Agreement may be waived (either generally or in a
particular instance and either retroactively or prospectively) only with the written consent of the party making the waiver. 
 6.9
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be held to be prohibited by or invalid under
applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement. 

6.10 Aggregation of Stock. All shares of Series F Stock held or acquired by Affiliates shall be aggregated together for the
purpose of determining the availability of any rights under this Agreement. 
 (Remainder of page intentionally left blank) 

  
 -6- 

 IN WITNESS WHEREOF, the parties hereto have executed this Allocation Agreement effective as of
the day and year first above written. 
  

			
	 APPDYNAMICS, INC.
 a Delaware
corporation

		
	By:	 	/s/ Randy Gottfried
	 Name: Randy Gottfried
 Title: Chief
Financial Officer

  

			
	
	GENERAL ATLANTIC (AD), L.P.
	
	BY: GENERAL ATLANTIC (SPV) GP, LLC, its general partner
	
	BY: GENERAL ATLANTIC LLC, its sole member
		
	By:	 	/s/ Thomas J. Murphy
	 Name: Thomas J. Murphy
 Title:
Managing Member

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]